Japan completes clinical trials of NMN intravenous injection
Japan completes clinical trials of NMN intravenous injection: significantly reduces blood lipids and is safe and reliable Numerous clinical trials have confirmed that oral NMN (nicotinamide mononucleotide) can safely and effectively increase NAD+(nicotinamide adenine dinucleotide) levels and improve various symptoms caused by aging. Although intravenous injection of nicotinamide mononucleotide still commonly used in animal experiments…